Astrazeneca Shs Sponsored American Deposit Receipt Repr 1 Sh $73.89

down -0.59


28/7/2014 04:00 PM  |  NYSE : AZN  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get AZN Trend Analysis - it has outperformed the S&P 500 by 29%

Partner Headlines

  1. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  2. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD
  3. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  4. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
  5. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  6. I Believe AstraZeneca Is Fairly Valued

    GuruFocus
  7. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  8. British Blue Chips Beckon

    Benzinga
  9. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  10. In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK

    FoxBusiness
  11. Dow Trades Above 17,000 While S&P 500 Inches Closer To 2,000

    Benzinga
  12. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  13. S&P: Cut Corporate Taxes to Create 10M New Jobs

    FoxBusiness
  14. Rumor Of Massive Monsanto-Syngenta Deal Gets Agriculture Sector Moving

    Benzinga
  15. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  16. Global M&A Up 73% To $1.6 Trillion; Health, Media Top

    IBD
  17. Medtronic to Buy Covidien for $42.0 Billion

    FoxBusiness
  18. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  19. Morning Market Movers

    Benzinga
  20. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  21. ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

    Benzinga
  22. M&A Activity Fearless Against Rate Hikes

    FoxBusiness
  23. AstraZeneca sees deal hurdles

    IBD
  24. A Bitter Pill

    FoxBusiness
  25. UPDATE: Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals ...

    Benzinga
  26. Allergan May Get Higher Bid

    IBD
  27. Market Wrap For May 13: Markets Close Again At Record Highs

    Benzinga
  28. AstraZeneca Would Weigh Strong Pfizer Offer

    FoxBusiness
  29. 7 Stocks For Your Retirement Portfolio

    Benzinga
  30. Stock Futures Up Ahead of Retail Sales Reading

    FoxBusiness
  31. Wall Street Edges Up, Builds on Record Highs

    FoxBusiness
  32. Allergan Rejects Valeant Bid

    IBD
  33. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  34. Pfizer Defends AstraZeneca Deal

    FoxBusiness
  35. Benzinga's Weekend M&A Chatter

    Benzinga
  36. Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca ...

    GuruFocus
  37. Defensive Stocks In Spotlight

    IBD
  38. Amgen

    IBD
  39. Pfizer getting heat over buyout

    IBD
  40. Horizon guides '14 sales up

    IBD
  41. Can Pfizer Make Up Its Loss?

    GuruFocus
  42. Will The U.K.'s Business Department Block Pfizer's Bid?

    Benzinga
  43. Horizon Pharma Q1 Beats Street; Guidance Mixed

    IBD
  44. Benzinga's M&A Chatter for Thursday May 8, 2014

    Benzinga
  45. Pfizer's Heart Races Of AstraZeneca Amidst Rumored Deal & Drug Approval

    Benzinga
  46. If Berkshire Hoards Cash, What About Google?

    YCharts
  47. AstraZeneca Touts Pipeline

    IBD
  48. Market Wrap For May 6: Dow Suffers Triple-Digit Point Loss, Nasdaq Underperforms ...

    Benzinga
  49. Sell-In-May: Seasonal Winners and Losers Listed

    YCharts
  50. AstraZeneca Woos Shareholders With Promise Of Growth

    IBD
Trading Center